Riskpilot← Back to searchSign inGet full accessSelskabet af 24. jan 2018 ApS
APSBankruptCVR 39276321Vamdrupvej 1B, 2. thOther education n.e.c. · NACE 8559Est. 2018— employeeswww.frontmed.dk
Revenue 2023
DKK 6K
-98% vs 2022
EBITDA margin
-1.9%
-100% vs 2022
Equity ratio
-86.2%
Financial strength
Net profit 2023
DKK 2K
-98% vs 2022
| Revenue | DKK 6K | -98% |
| EBITDA | DKK -120 | -100% |
| Net profit | DKK 2K | -98% |
| Total assets | DKK 123K | +11% |
| Equity | DKK -106K | +2% |
| Employees | — | — |
Legal name
Selskabet af 24. jan 2018 ApS
CVR number
39276321
Legal form
Anpartsselskab
NACE code
8559 · Other education n.e.c.
Founded
24. januar 2018
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at drive virksomhed med undervisning indenfor det præhospitale
område, supplerende virksomhed af sundhedsfagligt personale til relaterede opgaver samt
udvikling af udstyr til præhospital virksomhed og hermed efter ledelsens skøn beslægtet
virksomhed.
Address
Vamdrupvej 1B, 2. th
Email
info@frontmed.dk
Website
www.frontmed.dk
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | -147 | 138 | 96 | 278 | 6 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -147 | -36 | 27 | 127 | -0 |
| Depreciation & amort. | -6 | -13 | -11 | -29 | -0 |
| EBIT | -153 | -49 | 16 | 99 | -0 |
| Net financials | -5 | -7 | -27 | -6 | 2 |
| Profit before tax | -158 | -56 | -11 | 93 | 2 |
| Tax | -0 | -0 | -2 | 21 | 0 |
| Net profit | -158 | -56 | -9 | 72 | 2 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 137 | 173 | 83 | 111 | 123 |
| Equity | -125 | -180 | -180 | -108 | -106 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 262 | 354 | 263 | 218 | 229 |
| Total debt | 262 | 354 | 263 | 218 | 229 |
EBITDA margin
-1.9%
This company
15.8%
Market median
-112% vs market
20192023
Equity ratio
-86.2%
This company
38.2%
Market median
-326% vs market
20192023
Return on equity
169800.0%
This company
18.4%
Market median
+922726% vs market
20192023
Net profit margin
26.2%
This company
8.1%
Market median
+223% vs market
20192023
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20192023
Debt / equity
2.16×
This company
0.62×
Market median
-248% vs market
20192023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
FL Unofficial title | Unofficial title | 2025 – 2025 |
AK Unofficial title | Unofficial title | 2019 – 2019 |
MJ Chief Executive Officer | Chief Executive Officer | 2020 – 2025 |
CJ Management | Management | 2019 – 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MJZ Holding ApS
Selskabet af 24. jan 2018 ApS Board members of Selskabet af 24. jan 2018 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Finn Lynge Jepsen | Unofficial title | 0 companies |
| Andreas Kærsgaard Mylin | Unofficial title | 0 companies |
| Mark Juul Zweidorff | Chief Executive Officer | 0 companies |
| Christoffer Juul Zweidorff | Management | 0 companies |